The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.
Open accessAbstract
Clonal activation of CD4+ and CD8+ T lymphocytes depends on binding of peptide-major histocompatibility complex (MHC) molecule complexes by their alpha/beta receptors, eventually resulting in sufficient aggregation to initiate second messenger generation. The nature of intracellular signals resulting from such T cell receptor (TCR) occupancy is believed to be independent of the specific structure of the ligand being bound, and to vary quantitatively, not qualitatively, with the concentration of ligand offered and the affinity of the receptor for the peptide-MHC molecule complex. In contrast to the expectations of this model, the analysis of the response of a T helper type 1 clone to mutant E alpha E beta k molecules in the absence or presence of a peptide antigen revealed that peptide inhibited the interleukin 2 (IL-2) response to an otherwise allostimulatory mutant form of this MHC class II molecule. The inhibition was not due to competition for formation of alloantigen, it required TCR recognition of peptide-mutant MHC molecule complexes, and it decreased IL-2 production without affecting receptor-dependent IL-3, IL-2 receptor alpha, or size enlargement responses. This preferential reduction in IL-2 secretion could be correlated with the costimulatory signal dependence of this cytokine response, but could not be overcome by crosslinking the CD28 molecule on the T cell. These results define a new class of TCR ligands with mixed agonist/antagonist properties, and point to a ligand-related variation in the quality of clonotypic receptor signaling events or their integration with other signaling processes. It was also found that a single TCR ligand showed greatly different dose thresholds for the elicitation of distinct effector responses from a cloned T cell population. The observations that changes in ligand structure can result in qualitative alterations in the effects of receptor occupancy and that quantitative variations in ligand density can be translated into qualitative differences in T cell responses have important implications for models of intrathymic selection and control of the results of active immunization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435 · cited 1×
“In this regard, formation of an active signaling complex by the T cell is like association of univalent growth factor receptors that need to dimerize to signal (69).”
BackgroundRegulation of Interleukin-2 Gene Enhancer Activity by the T Cell Accessory Molecule CD28
Fraser, J. D., Irving, B. A., Crabtree, G. R., & Weiss, A. (1991) · Science · doi:10.1126/science.1846244 · Cited by 641
CD28 ligation in T-cell activation: evidence for two signal transduction pathways.
Ledbetter, J., Imboden, J., Schieven, G., Grosmaire, L., Rabinovitch, P., Lindsten, T., Thompson, C., & June, C. (1990) · Blood · doi:10.1182/blood.v75.7.1531.1531 · Cited by 170
Cited by
T cell receptor antagonist peptides induce positive selection
Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., & Carbone, F. R. (1994) · Cell · doi:10.1016/0092-8674(94)90169-4 · Cited by 2,858
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L., & Wiley, D. C. (1993) · Nature · doi:10.1038/364033a0 · Cited by 2,379
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
Constantinescu, C. S., Farooqi, N., O'Brien, K., & Gran, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01302.x · Cited by 1,523
Germain, R. N. (1994) · Cell · doi:10.1016/0092-8674(94)90336-0 · Cited by 1,434
Self-citationTh1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases
Liblau, R. S., Singer, S. M., & McDevitt, H. O. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80068-9 · Cited by 1,105
Moon, J. J., Chu, H. H., Pepper, M., McSorley, S. J., Jameson, S. C., Kedl, R. M., & Jenkins, M. K. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.007 · Cited by 976
Kinetic proofreading in T-cell receptor signal transduction.
McKeithan, T. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.5042 · Cited by 955
Signals and signs for lymphocyte responses
Janeway, C. A., & Bottomly, K. (1994) · Cell · doi:10.1016/0092-8674(94)90335-2 · Cited by 848
Stevens, D. A., Moss, R. B., Kurup, V. P., Knutsen, A. P., Greenberger, P., Judson, M. A., Denning, D. W., Crameri, R., Brody, A. S., Light, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376525 · Cited by 790
Sloan-Lancaster, J., & Allen, P. M. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.1 · Cited by 676
Madden, D. (1993) · Cell · doi:10.1016/0092-8674(93)90490-h · Cited by 675
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells
Sloan-Lancaster, J., Evavold, B. D., & Allen, P. M. (1993) · Nature · doi:10.1038/363156a0 · Cited by 587
Bertoletti, A., Sette, A., Chisari, F. V., Penna, A., Levrero, M., Carli, M. D., Fiaccadori, F., & Ferrari, C. (1994) · Nature · doi:10.1038/369407a0 · Cited by 540
ζ Phosphorylation Without ZAP-70 Activation Induced by TCR Antagonists or Partial Agonists
Madrenas, J., Wange, R. L., Wang, J. L., Isakov, N., Samelson, L. E., & Germain, R. N. (1995) · Science · doi:10.1126/science.7824949 · Cited by 505
Self-citationTCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways
Štefanová, I., Hemmer, B., Vergelli, M., Martin, R., Biddison, W. E., & Germain, R. N. (2003) · Nature Immunology · doi:10.1038/ni895 · Cited by 465
“Among the ligands that give rise to this incomplete pattern of early TCR signaling are antagonists, which are low-affinity peptide-MHC complexes that inhibit the responses of T cells in the presence of otherwise stimulatory receptor ligand”
BackgroundSelf-citationDevelopment and Selection of T Cells: Facts and Puzzles
Kisielow, P., & Von Boehmer, H. (1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60620-3 · Cited by 444
Germain, R. N., & Stefanová, I. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.467 · Cited by 436
Self-citationAn altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B., & Kuchroo, V. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90169-8 · Cited by 412
Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants
Klenerman, P., Rowland-Jones, S., McAdam, S., Edwards, J., Daenke, S., Lalloo, D., Köppe, B., Rosenberg, W., Boyd, D., Edwards, A., et al. (1994) · Nature · doi:10.1038/369403a0 · Cited by 412
Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands
Evavold, B. D., Sloan-Lancaster, J., & Allen, P. M. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90200-5 · Cited by 410
Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo.
Pfeiffer, C., Stein, J., Southwood, S., Ketelaar, H., Sette, A., & Bottomly, K. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1569 · Cited by 388
Anergic T Cells as Suppressor Cells in Vitro
Lombardi, G., Sidhu, S., Batchelor, R., & Lechler, R. (1994) · Science · doi:10.1126/science.8202711 · Cited by 366
TIM-4 is the ligand for TIM-1, and the TIM-1–TIM-4 interaction regulates T cell proliferation
Meyers, J. H., Chakravarti, S., Schlesinger, D., Illes, Z., Waldner, H., Umetsu, S. E., Kenny, J., Zheng, X. X., Umetsu, D. T., DeKruyff, R. H., et al. (2005) · Nature Immunology · doi:10.1038/ni1185 · Cited by 365
T cell receptor antagonists and partial agonists
Jameson, S. C., & Bevan, M. J. (1995) · Immunity · doi:10.1016/1074-7613(95)90074-8 · Cited by 298
Reis e Sousa, C., & Germain, R. N. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.841 · Cited by 296
Self-citationInvolvement of p21ras distinguishes positive and negative selection in thymocytes.
Swan, K. A., Alberola-Ila, J., Gross, J. A., Appleby, M. W., Forbush, K. A., Thomas, J. F., & Perlmutter, R. M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07001.x · Cited by 272
Mannie, M. D. (1999) · Immunologic Research · doi:10.1007/bf02786477 · Cited by 265
Jameson, S. C., Carbone, F. R., & Bevan, M. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1541 · Cited by 260
Metadata
- Authors
- Racioppi, L., Ronchese, F., Matis, L. A., & Germain, R. N.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1993-04-01
- Volume
- 177
- Issue
- 4
- Pages
- 1047-1060
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W1966598940
- Cited by
- 234
- References
- 3
- FWCI
- 12.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.